This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Universal American Corp. Reports 2011 Fourth Quarter And Full Year Results

Universal American Corp. (NYSE: UAM) today announced financial results for the quarter and year ended December 31, 2011.

Fourth Quarter 2011

Universal American’s reported net loss for the fourth quarter of 2011 was $20.0 million, or $0.25 per share. Adjusted net income 1 for the fourth quarter of 2011 was $10.4 million, or $0.13 per share, which excludes the following after-tax items:

  • $25.5 million, or $0.31 per share, of charges incurred in connection with cost reduction initiatives in our Medicare Advantage, Traditional and Corporate segments, the realignment of our distribution channels and other special items;
  • $1.4 million, or $0.02 per share, of loss from discontinued operations related to our previously-owned Medicare Part D business that was sold on April 29, 2011;
  • $1.4 million, or $0.02 per share, of non-recurring tax expense;
  • $1.1 million, or $0.02 per share, of transaction costs associated with the pending acquisition of APS Healthcare, Inc.; and
  • $1.0 million, or $0.01 per share, of net realized investment losses.

Total revenues from continuing operations for the fourth quarter of 2011 were $529 million.

_____________________ 1 Please see the discussion of Non-GAAP Financial Measures contained in the Supplemental Financial Information at the end of this press release for a reconciliation of adjusted net income to net (loss) income and other reconciliations.

Full Year 2011

Universal American’s reported net loss for the full year 2011 was $43.0 million, or $0.53 per share. Adjusted net income for the full year 2011 was $30.3 million, or $0.38 per share, which excludes the following after-tax items:

  • $43.3 million, or $0.54 per share, of loss from discontinued operations (including transaction costs) related to our previously-owned Medicare Part D business that was sold on April 29, 2011;
  • $5.6 million, or $0.07 per share, of non-recurring after-tax expenses related to the accelerated vesting of options and restricted stock as part of the Part D sale;
  • $25.5 million, or $0.31 per share, of charges incurred in connection with cost reduction initiatives in our Medicare Advantage, Traditional and Corporate segments, the realignment of our distribution channels and other special items;
  • $1.7 million, or $0.02 per share, of non-recurring tax benefits;
  • $1.1 million, or $0.02 per share, of transaction costs associated with the pending acquisition of APS Healthcare, Inc.; and
  • $0.5 million, or less than $0.01 per share, of net realized investment gains.

Total revenues from continuing operations for the full year of 2011 were $2.3 billion.

1 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs